870694-43-2

Basic information

• Product Name: 2-bromo-1-(5-bromopyridin-2-yl)ethanone
• Synonyms: 2-bromo-1-(5-bromopyridin-2-yl)ethanone
• CAS NO: 870694-43-2
• Molecular Formula: C₇H₅Br₂NO
• Molecular Weight: 278.9287
• Mol File: 870694-43-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 308.3±32.0 °C(Predicted)
• Appearance: /
• Density: 1.943±0.06 g/cm3(Predicted)
• PKA: -0.30±0.10(Predicted)
• CAS DataBase Reference: 2-bromo-1-(5-bromopyridin-2-yl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-1-(5-bromopyridin-2-yl)ethanone(870694-43-2)
• EPA Substance Registry System: 2-bromo-1-(5-bromopyridin-2-yl)ethanone(870694-43-2)

Safety Data

• Hazardous Substances Data: 870694-43-2(Hazardous Substances Data)

Upstream product

• 870694-29-4 2-bromo-1-(5-bromopyridin-2-yl)ethanone hydrobromide 
• 214701-49-2 1-(5-bromopyridin-2-yl)ethanone 
• 97483-77-7 2-Cyano-5-bromopyridine 

Downstream Products

• 870694-34-1 1-(5-bromopyridin-2-yl)ethane-1,2-diol 
• 870694-42-1 1-[2-(5-bromopyridin-2-yl)-2-oxoethyl]-2,5-dimethyl-3-trityl-1H-imidazol-3-ium bromide 

Relevant articles and documents

MORPHOLIN-PYRIDINE DERIVATIVES

The present invention relates to compounds of formula (I) wherein X is CR or N; R is hydrogen, halogen or lower alkyl; L is a bond, -C(O)- or -C(O)NH-; Ar is phenyl or a five or six membered heteroaryl group, containing one or two N atoms; R1 i

ANTIMICROBIAL HETEROCYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS

The present invention provides heterocyclic compounds of the following formula (I) : or pharmaceutically acceptable salts, prodrugs, solvates, or hydrates thereof useful as antibacterial agents, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.

3- `4- {6-SUBSTITUTED ALKANOYL) PYRIDIN-3-YL} -3-PHENYL! -5- (1H-1, 2, 3-TRIAZOL-1-YLMETHYL) -1, 3-OXAZOLIDIN-2-ONES AS ANTIBACTERIAL AGENTS

Compounds of formula (I) as well as pharmaceutically-acceptable salts and pro-drugs thereof are disclosed wherein R1, R2, R3, and R4 are defined herein. Also disclosed are processes for making compounds of formula (I) as well as methods of using compounds of formula (I) for treating bacterial infections.